We identified the proinflammatory IL6 pathway as a novel oncogenic cooperation partner of HH/GLI in BCC and show that HH/GLI and IL6/STAT3 signaling interact at the level of cis‐regulatory elements of common HH‐IL6 target genes. This evidence concerns the gene GLI1 and skin basal cell carcinoma.